HCA:NYE-HCA Holdings Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 331.69

Change

+3.98 (+1.21)%

Market Cap

USD 26.31B

Volume

1.03M

Analyst Target

USD 147.05
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
UHS Universal Health Services Inc

+0.96 (+0.58%)

USD 11.68B
DVA DaVita HealthCare Partners Inc

+0.74 (+0.56%)

USD 11.67B
FMS Fresenius Medical Care Corpora..

-0.11 (-0.54%)

USD 11.00B
THC Tenet Healthcare Corporation

-1.38 (-1.42%)

USD 10.22B
CHE Chemed Corp

-12.92 (-2.25%)

USD 9.53B
EHC Encompass Health Corp

-0.26 (-0.31%)

USD 7.66B
SEM Select Medical Holdings

+0.02 (+0.07%)

USD 3.87B
AMN AMN Healthcare Services Inc

+0.87 (+1.55%)

USD 2.13B
AGL agilon health Inc

-0.13 (-2.53%)

USD 2.11B
USPH US Physicalrapy Inc

+0.23 (+0.23%)

USD 1.60B

ETFs Containing HCA

FHI-B:CA CI Health Care Giants Cov.. 5.12 % 0.00 %

N/A

CAD 0.05B
YALL God Bless America ETF 4.94 % 0.00 %

-0.01 (0.00%)

USD 0.07B
ZWHC:CA BMO Covered Call Health C.. 4.82 % 0.00 %

N/A

CAD 0.01B
RUFF ETF Opportunities Trust -.. 4.29 % 0.00 %

+0.10 (+0.00%)

USD 0.06B
MHG:AU Magellan Global Equities 4.24 % 0.00 %

+0.01 (+0.00%)

USD 0.11B
MGE:AU 4.11 % 0.00 %

N/A

N/A
FXH First Trust Health Care A.. 0.00 % 0.63 %

+0.18 (+0.00%)

USD 1.33B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.19 (0.00%)

USD 0.82B
NASH 0.00 % 0.49 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

-0.14 (0.00%)

USD 1.09B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.07 %

-0.01 (0.00%)

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.54% 78% C+ 93% A
Dividend Return 0.24% 40% F 12% F
Total Return 22.78% 78% C+ 93% A
Trailing 12 Months  
Capital Gain 28.88% 63% D 79% B-
Dividend Return 0.72% 33% F 7% C-
Total Return 29.60% 56% F 77% C+
Trailing 5 Years  
Capital Gain 154.40% 95% A 91% A-
Dividend Return 6.76% 45% F 22% F
Total Return 161.16% 95% A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 25.83% 88% B+ 89% A-
Dividend Return 26.79% 88% B+ 88% B+
Total Return 0.96% 44% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 39.39% 50% F 26% F
Risk Adjusted Return 68.03% 96% N/A 91% A-
Market Capitalization 26.31B 100% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.50 61% 50%
Price/Book Ratio 293.44 4% 0%
Price / Cash Flow Ratio 9.03 33% 41%
Price/Free Cash Flow Ratio 9.91 41% 42%
Management Effectiveness  
Return on Equity 12.34% 60% 65%
Return on Invested Capital 21.91% 93% 88%
Return on Assets 11.08% 96% 94%
Debt to Equity Ratio -2,095.21% 100% 99%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.